A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
for Hidradenitis Suppurativa
Drug: Zasocitinib
Sites in Dallas, Arlington +13 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT07244263·Phase 2·Recruiting·Listed Nov 2025
Paid Clinical Trials in Texas
Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
4,652 clinical trials
Get a weekly email when new trials open in Houston, TX.
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for SLE
Sites in Plano, Webster +8 more locations
Sponsor: Cullinan Therapeutics Inc.
Sex: All·Age: 18 - 70
Code: NCT06613360·Phase 1·Recruiting·Listed Sep 2024
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
for Primary Membranous Nephropathy
Sites in Houston, Lufkin +17 more locations
Sponsor: Cerium Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05696613·Phase 3·Recruiting·Listed Jan 2023
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for Breast Cancer
Sites in Houston, San Antonio +20 more locations
Sponsor: Celcuity Inc
Sex: All·Age: 18+
Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
for Benign Prostatic Hyperplasia
Sites in Houston, Austin +17 more locations
Sponsor: Rivermark Medical
Sex: Male·Age: 45+
Code: NCT06849258·Recruiting·Listed Feb 2025
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
for Metastatic Castration-resistant Prostate Cancer
Sites in San Antonio +12 more locations
Sponsor: K36 Therapeutics, Inc.
Sex: Male·Age: 18+
Code: NCT07103018·Phase 1·Recruiting·Listed Aug 2025
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for Non-small Cell Lung Cancer (NSCLC)
Sites in Houston, Dallas +15 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06040541·Phase 1·Recruiting·Listed Sep 2023
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for Cholangiocarcinoma
Drug: Trametinib
Sites in Houston +7 more locations
Sponsor: Genfit
Sex: All·Age: 18+
Code: NCT05874414·Phase 1, Phase 2·Recruiting·Listed May 2023
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
for Coagulation Disorder
Sites in Dallas +12 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT05156983·Phase 3·Recruiting·Listed Dec 2021
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
for Pruritus
Drug: Dupilumab
Sites in Sugar Land +16 more locations
Sponsor: Sanofi
Sex: All·Age: 18 - 90
Code: NCT05263206·Phase 3·Recruiting·Listed Mar 2022
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for Multiple Myeloma
Drug: Linvoseltamab
Sites in Dallas +12 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05137054·Phase 1·Recruiting·Listed Nov 2021
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
for Familial Adenomatous Polyposis
Sites in Houston, Dallas +5 more locations
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT05552755·Phase 1, Phase 2·Recruiting·Listed Sep 2022
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Austin, The Woodlands +19 more locations
Sponsor: Loxo Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06588478·Phase 2·Recruiting·Listed Sep 2024
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
for Cerebral Vasospasm
Sites in Houston, Harlingen +14 more locations
Sponsor: Vesalio
Sex: All·Age: 22+
Code: NCT06893588·Recruiting·Listed Mar 2025
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
for Schizophrenia
Sites in Austin +21 more locations
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18+
Code: NCT07105111·Phase 4·Recruiting·Listed Aug 2025
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
for Migraine
Sites in San Antonio +13 more locations
Sponsor: H. Lundbeck A/S
Sex: All·Age: 6 - 17
Code: NCT05164172·Phase 3·Recruiting·Listed Dec 2021
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for Non-small Cell Lung Cancer (NSCLC)
Sites in Houston, Dallas +19 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05379985·Phase 1, Phase 2·Recruiting·Listed May 2022
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
for Non-Small Cell Lung Cancer
Sites in Houston, Dallas +14 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06917079·Phase 1·Recruiting·Listed Apr 2025
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Sites in Houston +15 more locations
Sponsor: Electra Therapeutics Inc.
Sex: All·Age: 6+
Code: NCT05416307·Phase 2, Phase 3·Recruiting·Listed Jun 2022
A Study of PYX-201 in Advanced Solid Tumors
for Solid Tumor
Sites in Houston, Dallas +15 more locations
Sponsor: Pyxis Oncology, Inc
Sex: All·Age: 18+
Code: NCT05720117·Phase 1·Recruiting·Listed Feb 2023
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for Solid Tumor
Sites in Irving +10 more locations
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT07094204·Phase 1·Recruiting·Listed Jul 2025
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-Resistant Prostate Cancer
Sites in Austin +13 more locations
Sponsor: Zenith Epigenetics
Sex: Male·Age: 18+
Code: NCT04986423·Phase 2·Recruiting·Listed Aug 2021
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
for Metastatic Uveal Melanoma
Sites in Houston +6 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT03947385·Phase 1, Phase 2·Recruiting·Listed May 2019
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
for Pemphigus Vulgaris
Sites in Houston, Dallas +8 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18+
Code: NCT04422912·Phase 1, Phase 2·Recruiting·Listed Jun 2020
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
for Peripheral T Cell Lymphoma
Sites in Houston, Temple +7 more locations
Sponsor: Acrotech Biopharma Inc.
Sex: All·Age: 18+
Code: NCT06072131·Phase 3·Recruiting·Listed Oct 2023
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
for Migraine
Sites in Austin +12 more locations
Sponsor: AbbVie
Sex: All·Age: 18 - 70
Code: NCT06602479·Phase 2·Recruiting·Listed Sep 2024
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for Familial Adenomatous Polyposis (FAP)
Sites in Houston +17 more locations
Sponsor: Rapamycin Holdings Inc.
Sex: All·Age: 18+
Code: NCT06950385·Phase 3·Recruiting·Listed Apr 2025
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
for Crohn's Disease
Drug: Upadacitinib
Sites in San Antonio, Tyler +7 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 65
Code: NCT06227910·Phase 3·Recruiting·Listed Jan 2024
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for Lower Respiratory Tract Infection
Sites in Houston, Dallas +17 more locations
Sponsor: Ansun Biopharma, Inc.
Sex: All·Age: All ages
Code: NCT03808922·Phase 3·Recruiting·Listed Jan 2019
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
for PDAC
Sites in Houston, Irving +16 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
for Nausea
Sites in Houston +11 more locations
Sponsor: Enterra Medical, Inc.
Sex: All·Age: 18+
Code: NCT06464926·Recruiting·Listed Jun 2024
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for Mid Face Volume Deficit
Sites in Austin +14 more locations
Sponsor: AbbVie
Sex: All·Age: 22+
Code: NCT06734351·Phase 3·Recruiting·Listed Dec 2024
EFS of the DUO System for Tricuspid Regurgitation
for Tricuspid Regurgitation
Sites in San Antonio +11 more locations
Sponsor: CroiValve Limited
Sex: All·Age: 18+
Code: NCT05913908·Recruiting·Listed Jun 2023
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
for Focal Segmental Glomerulosclerosis
Drug: Sparsentan
Sites in Houston +16 more locations
Sponsor: Travere Therapeutics, Inc.
Sex: All·Age: 1 - 17
Code: NCT05003986·Phase 2·Recruiting·Listed Aug 2021
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for Advanced Hepatocellular Carcinoma
Sites in Houston, Dallas +13 more locations
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06600321·Phase 1·Recruiting·Listed Sep 2024
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
for LGLL - Large Granular Lymphocytic Leukemia
Sites in Houston +14 more locations
Sponsor: Dren Bio
Sex: All·Age: 18+
Code: NCT05475925·Phase 1, Phase 2·Recruiting·Listed Jul 2022
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
for Acute Ischemic Stroke
Sites in Houston +13 more locations
Sponsor: Pharmazz, Inc.
Sex: All·Age: 18 - 80
Code: NCT05691244·Phase 3·Recruiting·Listed Jan 2023
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for Spinal Muscular Atrophy
Drug: Apitegromab
Sites in Houston, Dallas +12 more locations
Sponsor: Scholar Rock, Inc.
Sex: All·Age: Up to 2
Code: NCT07047144·Phase 2·Recruiting·Listed Jul 2025
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for Cancer
Sites in Houston, San Antonio +10 more locations
Sponsor: Alterome Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06835569·Phase 1·Recruiting·Listed Feb 2025
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for Infertility (IVF Patients)
Sites in Webster, Bedford +14 more locations
Sponsor: Granata Bio Corporation
Sex: Female·Age: 18 - 42
Code: NCT07216742·Phase 3·Recruiting·Listed Oct 2025